March 14, 2025 · Form 4 insider transaction
Meisner Lara sold 30,246 shares of BICARA THERAPEUTICS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on November 13, 2024.; The shares underlying this option vest in sixteen equal quarterly installments following December 14, 2023, subject to the Reporting Person's continued service on each such vesting date.